| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |